top
Search terms
Results 1 - 10 of 14 - ordered by :
Pages: 1 2
Escardio

Stable all-comer coronary artery disease (CAD) patients referred for coronary angiography with at least two-vessel disease including the left anterior descending coronary artery, left main coronary ...

Date : 29/08/2018
Escardio

Depression has been associated with poor outcomes in coronary artery disease but previous studies have mainly looked at short term effects, primarily in patients who have had a myocardial infarction ...

Date : 16/03/2012
Escardio

While the investigator-initiated study showed that DAPT (a combination of aspirin and the P2Y12-receptor blocker clopidogrel) does not decrease the rate of major adverse cardiovascular and ...

Date : 31/08/2015
Escardio

Patients with acute coronary syndromes (ACS) who are at high risk for bleeding have significantly lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous ...

Date : 17/05/2016
Escardio

BARCELONA, Spain – Monday 1 September: In patients being treated for heart attack, complete revascularisation of all significantly blocked arteries leads to better outcomes compared to a ...

Date : 01/09/2014
Escardio

Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin ...

Date : 29/08/2016
Escardio

In 2016 the CROS study has shown that even in the era of statin use and acute revascularisation, multidisciplinary cardiovascular (CV) rehabilitation leads to significant reductions in morbidity and ...

Date : 18/01/2019
Escardio

The findings, presented today at the ESC and published simultaneously in the New England Journal of Medicine, provide information that will help guide clinical practice and resolve uncertainty over ...

Date : 01/09/2013
Escardio

Up to 50% of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease. Prior randomised trials found declines in composite outcomes with non-culprit ...

Date : 01/09/2019
Escardio

Professor Deepak L. Bhatt (Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA) describes the rationale for the study, which is the largest trial in type 2 ...

Date : 02/09/2019